Radhika Tripuraneni

Insider Reports History

Entity
Individual
Location
331 Oyster Point Boulevard, South San Francisco, CA
Signature
/s/ Jennifer Tousignant, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Radhika Tripuraneni:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Viridian Therapeutics, Inc.\DE Chief Medical Officer Stock Option (Right to Buy) 311K Mar 10, 2025 Direct
PROTHENA CORP PUBLIC LTD CO Chief Development Officer Stock Option (Right to Buy) 50K Feb 23, 2022 Direct
Terns Pharmaceuticals, Inc. Director Stock Option (Right to Buy) 10.7K Feb 1, 2025 Direct

Insider Reports Filed by Radhika Tripuraneni

Symbol Company Period Transactions Value $ Form Type Date Filed Role
VRDN Viridian Therapeutics, Inc.\DE Mar 10, 2025 1 $0 4 Mar 12, 2025 Chief Medical Officer
VRDN Viridian Therapeutics, Inc.\DE Mar 10, 2025 0 $0 3 Mar 12, 2025 Chief Medical Officer
TERN Terns Pharmaceuticals, Inc. Feb 1, 2025 1 $0 4 Feb 3, 2025 Director
TERN Terns Pharmaceuticals, Inc. Jul 1, 2024 1 $0 4 Jul 2, 2024 Director
TERN Terns Pharmaceuticals, Inc. Jun 10, 2024 1 $0 4 Jun 14, 2024 Director
TERN Terns Pharmaceuticals, Inc. Jun 12, 2023 1 $0 4 Jun 14, 2023 Director
TERN Terns Pharmaceuticals, Inc. Jul 26, 2022 1 $0 4 Jul 28, 2022 Director
TERN Terns Pharmaceuticals, Inc. Jul 26, 2022 0 $0 3 Jul 28, 2022 Director
PRTA PROTHENA CORP PUBLIC LTD CO Feb 23, 2022 1 $0 4 Feb 25, 2022 Chief Development Officer